PDF下载 分享
[1]殷晓春,李淑兰,张薇薇,等.牛血清白蛋白纳米载药粒子的制备及其释放性能的研究[J].甘肃中医药大学学报,2018,35(02):6-10.[doi:10.16841/j.issn1003-8450.2018.02.02]
 YIN Xiaochun,LI Shulan,ZHANG Weiwei,et al.Research on preparation and drug release performance of bovine serum albumin nano drug-loaded particles[J].Journal of Gansu University of Chinese Medicine,2018,35(02):6-10.[doi:10.16841/j.issn1003-8450.2018.02.02]
点击复制

牛血清白蛋白纳米载药粒子的制备及其释放性能的研究

参考文献/References:

[1] 陈影.双子表面活性剂浓度的测量方法[J].辽宁化工,2013,42(1):103-106.
[2] 欧阳向南,唐善法,刘霜,等.双子表面活性剂临界胶束浓度规律研究进展[J].断块油气田,2012,19(5):654-657.
[3] Tardi P G,Boman N L,Cullis P R.Liposomal doxorubicin[J].J Drug Target,1996,4(3):129-140.
[4] Drummond D C,Meyer O,Hong K,et al.Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors[J].Pharmacol Rev,1999,51(4):69-74.
[5] Harris L,Batist G,Belt R,et al.TLC D-99 study group,liposome encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma[J].Cancer,2002,94(1):25-36.
[6] Fang J,Nakamura H,Maeda H.The EPR effect:unique features of tumor blood vessels for drug delivery,factors involved,and limitations and augmentation of the effect[J]. Adv Drug Delivery Rev,2011,63(3):136-151.
[7] Hofheinz R D,Gnad-Vogt S U,Beyer U,et al.Liposomal encapsulated anti-cancer drugs[J].Anti-cancer Drugs,2005,16(7):691-707.
[8] Miolo G,Baldo P,Bidoli E,et al.Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicin[J].Tumori,2009,95(6):687-690.
[9] Wang T,Hartner W C,Gillespie J W,et al. Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein[J].Nanomedicine,2014,10(2):421-430.
[10] Akdogan Y,Emrullahoglu M,Tatlidil D,et al.EPR studies of intermolecular interactions and competitive binding of drugs in a drug-BSA binding model[J].Phys Chem Chem Phys,2016,18(32):22531-22539.
[11] Chen B,He X Y,Yi X Q,et al.Dual-peptide-functionalized albumin-based nanoparticles with pH-dependent self-assembly behavior for drug delivery[J]. ACS Appl Mater Interfaces,2015,7(28):15148-15153.
[12] Nayar S,Mir A,Ashok A,et al.Bovine serum albumin binding and drug delivery studies with PVA-ferrofluid[J].J Bionic Eng,2010,7:29-34.
[13] Kun R,Kis L,Drkhny I.Hydrophobization of bovine serum albumin with cationic surfactants with different hydrophobic chain length[J].Colloid Surface B,2010,79:61-68.
[14] Morton S W,Poon Z,Hammond P T.The architecture and biological performance of drug-loaded LbL nanoparticles[J].Biomaterials,2013,34(21):5328-5335.
[15] Yang Y,Wang Y,Zhu M,et al.RGO/AuNR/HA-5FU nanocomposite with multi-stage release behavior and efficient antitumor activity for synergistic therapy[J]. Biomater Sci,2017,5(5):990-1000.

备注/Memo

收稿日期:2017-07-07。
基金项目:2015年甘肃省陇原创新人才计划项目(2015-78);甘肃省自然科学基金项目(17JR5RA170);兰州市科技计划项目(2017-4-77)。
作者简介:殷晓春(1979-),女,副教授,理学博士,主要从事生物高分子材料的研究。

更新日期/Last Update: 1900-01-01